MHRA Metoclopramide Safety Recommendations

 In Clinical Guidelines, MRHA News and Safety Alerts

Metoclopramide (Maxolon®) used to treat nausea and vomiting.

The MHRA recommends that indications for use should be restricted due to the risk of neurological side-effects,  particularly in children and adolescents, those with higher doses or with long term treatment.

The maximum treatment period should be 5 days for all patients.  For children aged 1-18 years, prescribing is restricted to nausea and vomiting induced by chemotherapy, or post-operatively.

http://www.mhra.gov.uk/Safetyinformation/DrugSafetyUpdate/CON300404

 

Photo by CDC [Public domain], via Wikimedia Commons

Recent Posts

Start typing and press Enter to search

e-cigeraettes